Weight loss and metabolic health effects from energy-restricted Mediterranean and Central-European diets in postmenopausal women: A randomized controlled trial

Joanna Bajerska, Agata Chmurzynska, Agata Muzsik, Patrycja Krzyżanowska, Edyta Mądry, Anna M Malinowska, Jarosław Walkowiak, Joanna Bajerska, Agata Chmurzynska, Agata Muzsik, Patrycja Krzyżanowska, Edyta Mądry, Anna M Malinowska, Jarosław Walkowiak

Abstract

We conducted a randomized controlled trial to examine the effect of two energy-restricted diets on body weight (BW), visceral fat (VF) loss, and the risk factors for metabolic syndrome. A total of 144 centrally obese postmenopausal women were assigned to the moderate in fat Mediterranean diet (MED) or to the Central European diet (CED), which is moderate in carbohydrates and high in dietary fiber (DF), for 16 weeks. BW, waist circumference and VF were significantly reduced by 8.8%, 7.0%, and 24.6%, respectively, over the trial (P < 0.001), with no difference between groups. A similar trend was seen for total cholesterol, triglycerides, glucose, and blood pressure. Within each diet group, the more adherent participants lost significantly more BW than did their less adherent counterparts. VF was significantly reduced only in women who were more adherent to the CED, and the reduction in VF correlated with an increase in the proportion of DF. Short-term dietary treatment with the CED or the MED was associated with similar improvements in some anthropometric, lipid, and nonlipid parameters; however, adequate adherence to the prescribed diet is important in weight loss success and in achieving improvements in metabolic health.

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Flow diagram of subjects’ participation in the trial.
Figure 2
Figure 2
Mean percent body weight changes over 16 weeks of dietary intervention in the more adherent (filled square) and less adherent (open square) postmenopausal women from the CED (left side) and the MED (right side) groups, respectively. Data are presented as means (CI 95%), **P < 0.01, ***P < 0.001 for differences between level of adherence at respective time points.

References

    1. Lizcano F, Guzmán G. Estrogen deficiency and the origin of obesity during menopause. Biomed. Res. Int. 2014;2014:757461.
    1. Stachowiak G, Pertyński T, Pertyńska-Marczewska M. Metabolic disorders in menopause. Prz. Menopauzalny. 2015;14:59–64.
    1. Deibert P, et al. Effect of a weight loss intervention on anthropometric measures and metabolic risk factors in pre- versus postmenopausal women. Nutr. J. 2007;6:31.
    1. Aude YW, et al. The national cholesterol education program diet vs. a diet lower in carbohydrates and higher in protein and monounsaturated fat: A randomized trial. Arch. Intern. Med. 2004;164:2141–2146.
    1. Eilat-Adar S, Sinai T, Yosefy C, Henkin Y. Nutritional recommendations for cardiovascular disease prevention. Nutrients. 2013;5:3646–3683.
    1. Bach-Faig A, et al. Mediterranean Diet Foundation Expert Group. Mediterranean diet pyramid today: Science and cultural updates. Public Health Nutr. 2011;14:2274–2284.
    1. Davis C, Bryan J, Hodgson J, Murphy K. Definition of the Mediterranean diet: A literature review. Nutrients. 2015;7:9139–9153.
    1. Rodriguez-Cano A, et al. Dietary changes associated with improvement of metabolic syndrome components in postmenopausal women receiving two different nutrition interventions. Menopause. 2015;22:758–764.
    1. Babio N, et al. Mediterranean diets and metabolic syndrome status in the PREDIMED randomized trial. CMAJ. 2014;186:E649–E657.
    1. Salas-Salvadó J, et al. Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: One-year results of the PREDIMED randomized trial. Arch. Intern. Med. 2008;168:2449–2458.
    1. Babio N, et al. Adherence to the Mediterranean diet and risk of metabolic syndrome and its components. Nutr. Metab. Cardiovasc. Dis. 2009;19:563–570.
    1. Esposito K, Kastorini CM, Panagiotakos DB, Giugliano D. Mediterranean diet and weight loss: Meta-analysis of randomized controlled trials. Metab. Syndr. Relat. Disord. 2011;9:1–12.
    1. Papadaki A, Scott JA. The impact on eating habits of temporary translocation from a Mediterranean to a Northern European environment. Eur. J. Clin. Nutr. 2002;56:455–461.
    1. Olsen A, et al. Healthy Aspects of the Nordic Diet are related to lower total mortality. J. Nutr. 2011;141:639–644.
    1. Alberti KG, Zimmet P, Shaw J. & IDF Epidemiology Task Force Consensus Group. The metabolic syndrome new worldwide definition. Lancet. 2005;366:1059–1062.
    1. Alhassan S, Kim S, Bersamin A, King AC, Gardner CD. Dietary adherence and weight loss success among overweight women: Results from the A TO Z weight loss study. Int. J. Obes. (Lond.) 2008;32:985–991.
    1. Whitworth JA, Chalmers J. World Health Organization/International Society Of Hypertension (WHO/ISH) hypertension guidelines. Clin. Exp. Hypertens. 2004;26:747–752.
    1. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972;18:499–502.
    1. The Oxford Centre for Diabetes. Endocrinology & Metabolism. Diabetes Trial Unit. HOMA Calculator. (2018).
    1. Chmurzynska A, Malinowska AM, Twardowska-Rajewska J, Gawecki J. Elderly women: Homocysteine reduction by short-term folic acid supplementation resulting in increased glucose concentrations and affecting lipid metabolism (C677T MTHFR polymorphism) Nutrition. 2013;29:841–844.
    1. Li BW, Andrews KW, Pehrsson PR. Individual sugars, soluble, and insoluble dietary fiber contents of 70 high consumption foods. J. Food Compos. Anal. 2002;15:715–723.
    1. Spiller G. CRC Handbook of Dietary Fiber in Human Nutrition. Third Edition. Boca Raton: CRC Press; 2001.
    1. Blundell J, et al. Appetite control: Methodological aspects of the evaluation of foods. Obes. Rev. 2010;11:251–270.
    1. Chakraborty, H. & Gu, H. A mixed model approach for intent-to-treat analysis in longitudinal clinical trials with missing values. RTI Press publication No. MR-0009-0903. Research Triangle Park, NC: RTI International. (2018).
    1. Sacks FM, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N. Engl. J. Med. 2009;26:859–873.
    1. Makris AP, Foster GD. Dietary approaches to the treatment of obesity. Psychiatr. Clin. North Am. 2005;28:117–139.
    1. Han TS, Lean ME. A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovasc. Dis. 2016;25:2048004016633371.
    1. Makris A, Foster GD. Dietary approaches to the treatment of obesity. Psychiatr. Clin. North Am. 2011;34:813–827.
    1. Esposito K, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: A randomized trial. JAMA. 2004;292:1440–1446.
    1. Gibson AA, Sainsbury A. Strategies to improve adherence to dietary weight loss interventions in research and real-world settings. Behav. Sci. (Basel) 2017;7:E44.
    1. Vogels N, Westerterp-Plantenga MS. Categorical strategies based on subject characteristics of dietary restraint and physical activity, for weight maintenance. Int. J. Obes. (Lond.) 2009;29:849–857.
    1. Jensen MD. Role of body fat distribution and the metabolic complications of obesity. J. Clin. Endocrinol. Metab. 2008;93:S57–S63.
    1. de Souza RJ, et al. Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on fat mass, lean mass, visceral adipose tissue, and hepatic fat: Results from the POUNDS LOST trial. Am. J. Clin. Nutr. 2012;95:614–625.
    1. Rosqvist F, et al. Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans. Diabetes. 2014;63:2356–2368.
    1. Davis JN, Alexander KE, Ventura EE, Toledo-Corral CM, Goran MI. Inverse relation between dietary fiber intake and visceral adiposity in overweight Latino youth. Am. J. Clin. Nutr. 2009;90:1160–1166.
    1. Anderson JW, Gustafson NJ. Adherence to high-carbohydrate, high-fiber diets. Diabetes Educ. 1989;15:429–434.
    1. Schneeman BO. Soluble vs. insoluble fiber different physiological responses. Food Technol. 1987;47:81–82.
    1. El Khoury, D., Cuda, C., Luhovyy, B. L. & Anderson, G. H. Beta glucan: Health benefits in obesity and metabolic syndrome. J. Nutr. Metab. 2012, 10.1155/2012/851362 (2012).
    1. Bendall CL, et al. Central obesity and the Mediterranean diet: A systematic review of intervention trials. Crit. Rev. Food Sci. Nutr. 2017;17:1–15.
    1. Piers LS, Walker KZ, Stoney RM, Soares MJ, O’Dea K. Substitution of saturated with monounsaturated fat in a 4-week diet affects bodyweight and composition of overweight and obese men. Br. J. Nutr. 2003;90:717–727.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren